Leber hereditary optic neuropathy (LHON) is one of the most devastating forms of hereditary blindness. mainly affecting young men in their twenties with bilateral simul taneous or sequential loss of vision.
I LHON also affects some women and may occur at any age. Loss of vision is usually the only abnormality. with occasional reports of neurological abnormalities2 -lo and rare cases of visual recovery. I 1-1 3 Colour vision is abnonnal and there is a large centrocecal scotoma. Acutely the optic nerve may appear normal or may be slightly elevated with associated peri papillary telangiectasia. 14 Later, however, the disc becomes atrophic. Australia has a population nearing 17 million of whom 85% originate from the British Isles. Extensive clinical and genealogical research has identified virtually every I) . In most cases we have traced the families back further in the United Kingdom. Three sporadic cases with no family history of LHON were also identified.
IS
Mitochondrial DNA (mtDNA) analysis has identified several point mutations in the mtDNA and these are given for each of the large Australian families with multiple affected individuals. 16 From clinical studies of the differ ent families it was evident that there were some pheno typic differences between them6.17 and that these correlated with the genotype. I �.l9 Work in the United States has also shown that the various genotypes have variable phenotypes.211-23
METHOD
Patients and pedigrees were identified using the strategies outlined in the Methods section of the previous study. 15 With informed consent DNA was taken and studied for the various mtDNA mutations. 24 The primers for screening the 14484 mutation are outlined in the Method section of Johns ct al. 2 
RESULTS
For the total number of patients in the Australian pedi grees with LHON readers are referred to the earlier paper. 1 5 From these, 199 blind descendants of 13 families had the 11778 G to A mutation; 7 blind descendants of 2 families had the 3460 G to A mutation; 41 blind descend ants from I family had the 4160 T to C mutation and the 14484 T to C mutation; 66 blind descendants from 2 fam ilies had the 14484 T to C mutation and the 13708 G to A mutation. Only 1 Italian female had the isolated 15257 G to A mutation, while 7 members of a 1 1778 G to A family (already counted above) also had this mutation. There are 19 families here because the 3 singleton cases have been included with these mutations.
Mutation 11778
Mutation 11778 occurs in many families originating throughout the British Isles and is the most common muta tion. Of over 50 (from 92 living) patients with the 11778 mutation who were questioned directly or by telephone only I reported recovery of vision. Their acuities were all reported as less than 6/60, except I male who recovered to VR 6/36 VL 6/6. One female had associated mUltiple sclerosis affecting her lower limbs and bladder and severe visual loss consistent with LHON. Visual fields were examined in 10 males, including the male with recovery of vision from less than 6/60 in both eyes to VR 6/36 VL 6 /6, and all showed dense central scotomata. This patient who recovered had such a small island of vision within his cen trocecal scotoma that it could not be detected on any type of field examination (Fig. 2 ). Most could hardly do the Farnsworth-Munsell 100 Hue test and tended to have errors in the deutan axis. The classic triad of optic disc ele vation, peripapillary telangiectasia and no leakage on flu orescein angiography"6 had been photographed or seen in 12 patients, but probably was not reported in many cases because of the subtlety of these signs. The family with both the 1 1778 and 15257 mutations was not examined by the protocol described in the Method section, but all 7 individuals were reported to have dense centrocecal scoto mata and poor vision.
The mean age of loss of vision in the 1 1778 group (with or without other secondary mutations) was 26.1 ± 11.1 years (mean ± standard deviation) for 94 males and 27.7 ± 11.2 years for 17 females. The median age for visual loss, however, was 24 years.
Mutation 3460
Families with mutation 3460 originated from near London. Seven affected individuals from 2 families had the 3460 mutation."7 Two patients reported visual recovery from less than 6/60 in both eyes; I female could see VR 6/12 VL 6/ 12, with patchy field loss (Fig. 3) , while the other, a male, was slightly mentally retarded and could read VR 6/18 VL 6/ 18. The remaining 5 had dense cen trocecal scotomata and acuities less than 6/60. Colour vision loss was non-specific. Two patients had sensorineu ral hearing loss and 2 had epilepsy. The mean age of onset was 28,0 ± 7.0 years (the median age was also 28 years) for 5 males and 19,5 ± 2, 5 years for 2 females,
Mutation 14484
Families with mutation 14484 originated from south of London, and are genealogically a very old family with descendants in Australia, the United Kingdom and prob ably the United States. Both families with the 14484 and 13708 mutations'9 had a large number of individuals reco vering vision, Of 20 patients examined 50% had recovered from less than 6/60 in both eyes to visual acuities better than 6/24, Recovery was likely if the visual loss occurred before the median age of visual loss of 27 years. 1 9 The visual field usually showed a centrocecal scotoma; how- ever, in patients who recovered, the scotoma seemed to constrict rather than to fenestrate, leaving an enlarged blind spot. Recovery usually occurred over 6 months as the acuity improved (Fig. 4) . The best improvement docu mented was to VR 6/4 VL 6/4, with slight residual enlar gement of the blind spot. The visual recovery was documented at 2 monthly intervals over the acute phase of the disease in the younger brother of 2 affected patients (Fig. 5) . Most patients could do the Farnsworth-Munsell 100 Hue test and scored better than the 11778 patients, with an error more often in the tritan axis. The mean age of visual loss for 23 males was 29.0 ± 12.6 years and for 8 females, 27.4 ± 16.6 years,
Mutation 4160
The apparently unique family with mutation 4160 ori ginated from south of Glasgow. The Qld family with the 4160 and 14484 mutations was described well by David Wallace.6 Since his report no further episodes of juvenile encephalopathy have occurred, with the possible excep tion of one 23-year-old man who had a meningitis-like ill ness. Twelve of the 23 living affected individuals and 3 unaffected females and one as yet unaffected boy were examined. The age at onset of visual loss and neurological symptoms is sometimes difficult to state as many start in the first decade of life. Equally it is difficult to obtain reliable visual acuities at the worst stage of the disease in those who lost vision in the first decade, but most who lose vision as teenagers report that their acuities were less than 6/60. Every male over 10 years had some degree of visual loss ranging from VR 6/12 VL 6/18 and quite variable visual field loss (Fig. 6 ) to VR PL VL PL. Again there seemed to be better acuities in those who lost vision at a younger age. Neurological symptoms and signs could occur before or after the eye problems. Usually the first symptoms are of paresthaesiae in the hands and feet; later, variable sensory loss and spastic paraplegia may develop as well as dysarthria. One man lost vision at age 22 years and a year later had a meningitis-like illness. Now 10 years later he has severe visual loss (VR PL, VL PL), with paresthaesiae in the hands and feet, but no objective neurological findings. Three women aged 40 years, 25 years and 17 years were quite normal, as was one 10-year old boy. There was no documentation nor any photograph of classic LHON discs available. Colour vision loss was variable with the acuity and more often in the protan axis.
Mutation 15257?
One singleton Italian patient had the 15257 mutation and had lost vision to less than 6/60 in both eyes, then reco vered vision to 6/18 in both eyes. 2X She had no other neuro logical abnormalities. The Qld2 family had this mutation in association with the 11778 G to A mutation but seemed classic for the clinical description of the 11778 mutation. In the largest study on age of visual loss by Belli the age of visual loss for 669 males was 23.2 ± 10.0 years and for 113 females it was 25.2 ± 13.3 years. In the study by Newman et al. 20 on patients with the 11778 mutation, the age of onset of visual loss was 26.2 ± 13.0 years for 59 males and 34.0 ± 13.3 years for 13 females. This study has similar findings, loss of vision occurring at a mean age of 26.1 years for males and 27.7 years for females. All studies show a slight skew with a younger median age. lohns et al. 22 found a mean age of onset for men and women with the 3460 mutation of 29 years. lohns et al."' found a mean age of onset for men and women with the 14484 mutation of 27 years. This study gives similar results and importantly both of our groups show that the younger the age of onset the more likely the recovery of vision. This has important clinical and research signifi cance. When counselling a patient from a 14484 family who is young (less than 20 years) an optimistic prediction for some recovery of vision is possible. The potential for finding factors which may promote visual recovery in LHON is possible. Studies into the sUbpopulation of gan glion cells which recover are likely to give some clues as to the pathophysiological mechanism of the disorder. It was not possible to give the mean age of onset in the 4160 mutation accurately as this was often in the first decade, and children of this age are not reliable historians. The oldest male patient, to lose vision with the 4160 and 14484 mutations, however, was 22 years old. Onset of visual loss between the two eyes is virtually impossible to assess accurately as patients often miss the early subtle changes in the first eye.
Final Visual Acuity and Fields
The 11778 mutation is associated with a large centrocecal scotoma and rare recovery of vision. If recovery occurs it seems to be due to fenestration of the central scotoma.20.2 1 The rate of recovery, around 2% in this study, corresponds with that in other studies. 20 The 3460 mutation was associ ated with a greater rate of visual recovery (2 of 7), which is similar to the findings of lohns et al.22 of 20%. The 14484 families are definitely associated with a better visual prog nosis I 9.", and the patients in lohns et al. ' s study probably include members of the family from Montreaf9. 30 who showed consistent recovery in 50% of cases. The acuity and fields of the Qld I family with both the 4160 and 14484 mutations is similar to that of the other 14484 families, with recovery seeming to occur in younger-onset patients.
Colour Vision
It is not possible to compare accurately the colour vision in this study, but the results may suggest that a different popUlation of ganglion cells recover in the 14484 muta tion, where the error is mainly in the tritan axis. This may give some possible clues to the pathophysiology of LHON.
Neurological Abnormalities
Although LHON in women may be incorrectly diagnosed as multiple sclerosis (MS),]l an MS-like syndrome has been described in several studies.3.5.9loE33 So far only one patient with an MS-like syndrome carrying the 11778 mutation has been found in Australia.
Hearing loss was reported in some family members with the 3460 mutation. Pedigrees of mitochondrially inherited hearing loss are known,34 as are mitochondrial pedigrees of antibiotic-induced deafness.35.30 Brainstem auditory evoked potentials have been found to be abnormal in some cases of LHON,17 although these patients did not have hearing loss.
Association with Charcot-Marie-Tooth (CMT) disease has also been reported.3R.19 However, the Australian family NSW 13R with CMT and LHON has the 11778 mutation and the two diseases seem to be independently inherited.
Dystonia and LHON have been reported in a few fam ilies in the United States, The Netherlands and England.2.X. 40.4l The Qldl family with juvenile encephalopathy,61RA2-44 and probably with 100% penetrance, is unique. Qldl may possibly be related to the family described by Wilson. 4 The disease is becoming less severe in that no recent cases of death from juvenile encephalopathy have been described since the family was originally reported in 1970. Most of those affected with dysarthria, peripheral sensory loss and spasticity were affected at a young age and are now over 40 years old. Originally they were thought to have polio, although the symptoms were not really clinically similar.
ECG Findings
Preliminary electrocardiographic findings for families Tasl (l 1778), Tas2 (14484) and Tas3 (3460) were given by Bower et al. 45 and abnormalities do not appear to be any more frequent than in the general population.20 However, there were several cases of unexplained sudden death in early adult life, including the Tas3 patient reported.45
CONCLUSION
It is apparent from this study and those in the United States that mitochondrial genotypes are associated with varia tions in the phenotypes of LHON.
I. The 1 1778 G to A and 3460 G to A mutations are asso ciated with classic visual loss, rare recovery of vision (fenestration of the scotoma was seen if recovery occurred) and occasional neurological abnormalities (including an MS-like syndrome).
2. The 14484 T to C mutation is associated with frequent recovery of vision and constriction of the scotomata, especially if visual loss occurs at a younger age.
3. The 4160 T to C with the 14484 T to C mutation family (Qld I ) appears unique in the literature and is associated with almost 100% penetrance of the disorder. The visual loss is again quite variable, with patients losing vision at a younger age having a better final acuity and 435 field. Neurological abnormalities include the now rare juvenile encephalopathy and peripheral paresthaesiae with variable degrees of sensory loss, spasticity and dysarthria.
All three of these phenotypes have come from the United Kingdom. Thus genetic testing of at least one family member may confirm the diagnosis and allow a better understanding of the clinical prognosis for patients affected with LHON. Simpler methods of doing this DNA testing have recently been described.23.24
